Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.

about

Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.

Item

http://www.wikidata.org/entity/Q41997453

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pathologic response after preo ...... atients with liver metastases.

@en

type

Item

label

Pathologic response after preo ...... atients with liver metastases.

@en

prefLabel

Pathologic response after preo ...... atients with liver metastases.

@en

P1476

Pathologic response after preo ...... patients with liver metastases

@en

P2093

Bin-Kui Li

http://www.w3.org/2001/XMLSchema#string

De-Sen Wan

http://www.w3.org/2001/XMLSchema#string

Feng-Hua Wang

http://www.w3.org/2001/XMLSchema#string

Gong Chen

http://www.w3.org/2001/XMLSchema#string

Hao-Cheng Lin

http://www.w3.org/2001/XMLSchema#string

Pei-Rong Ding

http://www.w3.org/2001/XMLSchema#string

Peng Sun

http://www.w3.org/2001/XMLSchema#string

Shu-Mei Yan

http://www.w3.org/2001/XMLSchema#string

Xiao-Jun Wu

http://www.w3.org/2001/XMLSchema#string

Yu-Hong Li

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer.

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Incidence and mortality of colorectal cancer in China, 2011

Right-sided colon cancer and left-sided colorectal cancers respond differently to cetuximab.

Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy.

Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone

Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy

P2888

s40880-017-0244-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40880-017-0244-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rui-Hua Xu

P577

2017-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092052057

http://www.w3.org/2001/XMLSchema#string

P698

28969708

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5625647

http://www.w3.org/2001/XMLSchema#string